Plasma proteomics reveals early, broad release of chemokine, cytokine, TNF, and interferon mediators following trauma with delayed increases in a subset of chemokines and cytokines in patients that remain critically ill

Severe injury is known to cause a systemic cytokine storm that is associated with adverse outcomes. However, a comprehensive assessment of the time-dependent changes in circulating levels of a broad spectrum of protein immune mediators and soluble immune mediator receptors in severely injured trauma patients remains uncharacterized. To address this knowledge gap, we defined the temporal and outcome-based patterns of 184 known immune mediators and soluble cytokine receptors in the circulation of severely injured patients. Proteomics (aptamer-based assay, SomaLogic, Inc) was performed on plasma samples drawn at 0, 24, and 72 hours (h) from time of admission from 150 trauma patients, a representative subset from the Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock (PAMPer) trial. Patients were categorized into outcome groups including Early Non-Survivors (died within 72 h; ENS; n=38), Non-Resolvers (died after 72 h or required ≥7 days of intensive care; NR; n=78), and Resolvers (survivors that required < 7 days of intensive care; R; n=34), with low Injury Severity Score (ISS) patients from the Tranexamic Acid During Prehospital Transport in Patients at Risk for Hemorrhage After Injury (STAAMP) trial as controls. The major findings include an extensive release of immune mediators and cytokine receptors at time 0h that is more pronounced in ENS and NR patients. There was a selective subset of mediators elevated at 24 and 72 h to a greater degree in NR patients, including multiple cytokines and chemokines not previously described in trauma patients. These findings were validated in a quantitative fashion using mesoscale discovery immunoassays (MSD) from an external validation cohort (VC) of samples from 58 trauma patients matched for R and NR status. This comprehensive longitudinal description of immune mediator patterns associated with trauma outcomes provides a new level of characterization of the immune response that follows severe injury.

[1]  Upendra K. Kar,et al.  High Dimensional Multiomics Reveals Unique Characteristics of Early Plasma Administration in Polytrauma Patients With TBI , 2022, Annals of surgery.

[2]  C. Florence,et al.  Economic Cost of Injury — United States, 2019 , 2021, MMWR. Morbidity and mortality weekly report.

[3]  Upendra K. Kar,et al.  Multi-omic analysis in injured humans: Patterns align with outcomes and treatment responses , 2021, Cell reports. Medicine.

[4]  Y. Vodovotz,et al.  A putative “chemokine switch” that regulates systemic acute inflammation in humans , 2021, Scientific Reports.

[5]  Upendra K. Kar,et al.  The use of multiplexing to identify cytokine and chemokine networks in the immune-inflammatory response to trauma. , 2021, Antioxidants & redox signaling.

[6]  Y. Vodovotz,et al.  Protective/reparative cytokines are suppressed at high injury severity in human trauma , 2021, Trauma Surgery & Acute Care Open.

[7]  Qi Mi,et al.  Computational Derivation of Core, Dynamic Human Blunt Trauma Inflammatory Endotypes , 2021, Frontiers in Immunology.

[8]  D. Angus,et al.  A road map from single-cell transcriptome to patient classification for the immune response to trauma , 2020, JCI insight.

[9]  K. Clément,et al.  Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis , 2020, Science Translational Medicine.

[10]  M. Walter.  The Role of Structure in the Biology of Interferon Signaling , 2020, Frontiers in Immunology.

[11]  Y. Vodovotz,et al.  Early Dynamic Orchestration of Immunologic Mediators Identifies Multiply Injured Patients who are Tolerant or Sensitive to Hemorrhage. , 2020, The journal of trauma and acute care surgery.

[12]  C. Callaway,et al.  Tranexamic Acid During Prehospital Transport in Patients at Risk for Hemorrhage After Injury: A Double-blind, Placebo-Controlled, Randomized Clinical Trial. , 2020, JAMA surgery.

[13]  C. Stothers,et al.  The Metabolic Basis of Immune Dysfunction Following Sepsis and Trauma , 2020, Frontiers in Immunology.

[14]  F. Guyette,et al.  Prehospital plasma is associated with distinct biomarker expression following injury. , 2020, JCI insight.

[15]  A. Peitzman,et al.  Unsupervised Clustering Analysis Based on MODS Severity Identifies Four Distinct Organ Dysfunction Patterns in Severely Injured Blunt Trauma Patients , 2020, Frontiers in Medicine.

[16]  Jan W. Gooch.  Interleukin , 2020, Definitions.

[17]  Y. Vodovotz,et al.  An Aging-Related Single-Nucleotide Polymorphism is Associated with Altered Clinical Outcomes and Distinct Inflammatory Profiles in Aged Blunt Trauma Patients. , 2020, Shock.

[18]  Stephen A. Williams,et al.  Plasma protein patterns as comprehensive indicators of health , 2019, Nature Medicine.

[19]  Y. Vodovotz,et al.  MPPED2 Polymorphism Is Associated With Altered Systemic Inflammation and Adverse Trauma Outcomes , 2019, Front. Genet..

[20]  M. T. B. Geller,et al.  Molecular , 2019, Modern Pathology.

[21]  A. Peitzman,et al.  Computational evidence for an early, amplified systemic inflammation program in polytrauma patients with severe extremity injuries , 2019, PloS one.

[22]  Y. Vodovotz,et al.  Early Immunologic Response in Multiply Injured Patients With Orthopaedic Injuries Is Associated With Organ Dysfunction , 2019, Journal of orthopaedic trauma.

[23]  Ryan J. Stark,et al.  Late immune consequences of combat trauma: a review of trauma-related immune dysfunction and potential therapies , 2019, Military Medical Research.

[24]  Y. Vodovotz,et al.  Young and Aged Blunt Trauma Patients Display Major Differences in Circulating Inflammatory Mediator Profiles after Severe Injury. , 2019, Journal of the American College of Surgeons.

[25]  D. Brenner,et al.  The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond. , 2019, Physiological reviews.

[26]  F. Hildebrand,et al.  Using IL-6 concentrations in the first 24 h following trauma to predict immunological complications and mortality in trauma patients: a meta-analysis , 2018, European Journal of Trauma and Emergency Surgery.

[27]  G. Bernardini,et al.  Chemokine regulation of innate lymphoid cell tissue distribution and function. , 2018, Cytokine & growth factor reviews.

[28]  C. Callaway,et al.  Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock , 2018, The New England journal of medicine.

[29]  Stephen Burgess,et al.  Genomic atlas of the human plasma proteome , 2018, Nature.

[30]  R. Nibbs,et al.  A guide to chemokines and their receptors , 2018, The FEBS journal.

[31]  Qi Mi,et al.  Individual-specific principal component analysis of circulating inflammatory mediators predicts early organ dysfunction in trauma patients. , 2016, Journal of critical care.

[32]  A. Peitzman,et al.  Computational Analysis Supports an Early, Type 17 Cell-Associated Divergence of Blunt Trauma Survival and Mortality* , 2016, Critical care medicine.

[33]  Qi Mi,et al.  Insights into the Role of Chemokines, Damage-Associated Molecular Patterns, and Lymphocyte-Derived Mediators from Computational Models of Trauma-Induced Inflammation. , 2015, Antioxidants & redox signaling.

[34]  A. Luster,et al.  Chemokines and chemokine receptors: positioning cells for host defense and immunity. , 2014, Annual review of immunology.

[35]  Qi Mi,et al.  Central Role for MCP-1/CCL2 in Injury-Induced Inflammation Revealed by In Vitro, In Silico, and Clinical Studies , 2013, PloS one.

[36]  B. Aggarwal,et al.  Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. , 2012, Blood.

[37]  John D. Storey,et al.  A genomic storm in critically injured humans , 2011, The Journal of experimental medicine.

[38]  Tracy R. Keeney,et al.  Aptamer-based multiplexed proteomic technology for biomarker discovery , 2010, PloS one.

[39]  F. Schmidt.  Meta-Analysis , 2008 .

[40]  J. Oppenheim.  Cytokines, Their Receptors and Signals , 2020, The Autoimmune Diseases.

[41]  A. Peitzman,et al.  Temporal Patterns of Circulating Inflammation Biomarker Networks Differentiate Susceptibility to Nosocomial Infection Following Blunt Trauma in Humans. , 2016, Annals of surgery.

[42]  B. Diamond,et al.  Autoimmune diseases , 2000, Bone Marrow Transplantation.